ArticleDisease markers2019

Assessment of the Concentration of Bone Metabolism Markers: Sclerostin and FGF-23 in Children with Idiopathic Nephrotic Syndrome Treated with Glucocorticosteroids.

Agnieszka Pukajło-Marczyk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.